海(hai)(hai)(hai)南碧凱藥(yao)業(ye)有限(xian)公(gong)(gong)(gong)司成立(li)于1993年。公(gong)(gong)(gong)司擁(yong)有各類人才,員工近2000人。公(gong)(gong)(gong)司生(sheng)產基地(di)(di)位于海(hai)(hai)(hai)口藥(yao)谷,占地(di)(di)134畝,建(jian)筑面積10萬多平(ping)米。“海(hai)(hai)(hai)南碧凱藥(yao)物研究所有限(xian)公(gong)(gong)(gong)司”、“海(hai)(hai)(hai)南碧凱藥(yao)業(ye)有限(xian)公(gong)(gong)(gong)司”、“海(hai)(hai)(hai)南碧凱醫藥(yao)有限(xian)公(gong)(gong)(gong)司”研發、生(sheng)產、銷售婦科(ke)類、心腦血管類、補(bu)益類等品種,產品銷往全國(guo)各地(di)(di)及(ji)中(zhong)亞四國(guo)。
上(shang)世紀七十年(nian)代末,德國科學家(jia)Harald zur Hausen因(yin)提出持續性(xing)的(de)(de)HPV感(gan)(gan)染是(shi)宮(gong)(gong)頸癌(ai)發(fa)(fa)生(sheng)(sheng)的(de)(de)條件,使宮(gong)(gong)頸癌(ai)成為病因(yin)明確(que)可防可治(zhi)的(de)(de)癌(ai)癥,宮(gong)(gong)頸癌(ai)是(shi)女(nv)(nv)性(xing)第二大殺手。高危型HPV持續感(gan)(gan)染是(shi)宮(gong)(gong)頸癌(ai)前病變(bian)和宮(gong)(gong)頸癌(ai)發(fa)(fa)生(sheng)(sheng)的(de)(de)元兇。高達75%的(de)(de)女(nv)(nv)性(xing)在其一(yi)生(sheng)(sheng)中(zhong)可能感(gan)(gan)染HPV;30歲以(yi)上(shang)婦女(nv)(nv)HPV持續感(gan)(gan)染平(ping)均8~24個(ge)月,可發(fa)(fa)生(sheng)(sheng)宮(gong)(gong)頸癌(ai)前病變(bian)(CIN),平(ping)均8~12年(nian)可發(fa)(fa)展成浸潤癌(ai)。清除HPV,阻斷癌(ai)變(bian)進程,是(shi)預防宮(gong)(gong)頸癌(ai)的(de)(de)決定因(yin)素(su)。臨床(chuang)急需治(zhi)療HPV感(gan)(gan)染的(de)(de)藥物,但全球(qiu)尚(shang)無(wu)政府批準的(de)(de)治(zhi)療藥物。
經(jing)15年研(yan)究(jiu)證實:碧凱(kai)保婦康栓治療(liao)宮頸(jing)高(gao)危型HPV持續感染,安全有效(xiao)。